CD19/CD20 Double Knockout Raji Cell Line - 2 vials

Datasheet
Please note this product may be subject to fees, we invite you to contact your local office. CD19/CD20 Double Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) and CD20 (B-lymphocyte antigen CD20, or MS4A1) have been genetically removed from Raji cells using CRISPR/Cas9 genome editing. This cell line has been validated by genome sequencing and flow cytometry.

Supplier Catalog Number

 82623

Shipping conditions

 Dry ice

Storage Temperature

 -180°C

Supplier name

 BPS Bioscience
Contact Us

No surprise after checkout. All fees included

Your satisfaction first: door delivery with guaranteed replacement

Dedicated Scientific Support to select & use